<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai-pmh.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-25T01:14:58Z</responseDate>
  <request identifier="oai:www.ideals.illinois.edu:2142/129981" metadataPrefix="etdms" verb="GetRecord">https://www.ideals.illinois.edu/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:www.ideals.illinois.edu:2142/129981</identifier>
        <datestamp>2025-10-25</datestamp>
        <setSpec>col_2142_5131</setSpec>
        <setSpec>col_2142_14781</setSpec>
        <setSpec>com_2142_5130</setSpec>
        <setSpec>com_2142_687</setSpec>
        <setSpec>com_2142_397</setSpec>
      </header>
      <metadata>
        <thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdms11.xsd http://purl.org/dc/elements/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdmsdc.xsd">
          <dc:format>application/pdf</dc:format>
          <dc:language>en</dc:language>
          <dc:type>text</dc:type>
          <dc:description>Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2025-10-20 without embargo terms</dc:description>
          <dc:description>The student, Mariel Molina Castro, accepted the attached license on 2025-07-23 at 10:34.</dc:description>
          <dc:description>The student, Mariel Molina Castro, submitted this Thesis for approval on 2025-07-23 at 10:41.</dc:description>
          <dc:description>This Thesis was approved for publication on 2025-07-23 at 14:49.</dc:description>
          <dc:description>DSpace SAF Submission Ingestion Package generated from Vireo submission #22704 on 2025-10-20 at 20:15:41</dc:description>
          <dc:title>Endocrine responses to alcohol ingestion in women with and without metabolic surgery</dc:title>
          <dc:creator>Molina Castro, Mariel</dc:creator>
          <dc:date>2025-07-23</dc:date>
          <dc:contributor>Pepino, Marta Y.</dc:contributor>
          <dc:contributor>Miller, Michael</dc:contributor>
          <dc:contributor>Amengual, Jaume</dc:contributor>
          <dc:subject>Alcohol Use Disorder</dc:subject>
          <dc:subject>Weight-loss Surgery</dc:subject>
          <dc:subject>Glucose Metabolism</dc:subject>
          <dc:language>eng</dc:language>
          <dc:description>Glucagon-like peptide-1 (GLP-1)-based therapies, widely used for treating obesity and type 2 diabetes, also show potential for reducing alcohol-seeking behavior. However, the effects of alcohol on endogenous GLP-1 and related peptides remain poorly understood, especially in individuals who have undergone metabolic surgery, a group at elevated risk for alcohol use disorder (AUD) despite an enhanced GLP-1 response post-surgery. This work integrates findings from cross-sectional and longitudinal placebo-controlled studies that examined the acute endocrine and glycemic effects of alcohol ingestion in women with and without a history of metabolic surgery. In the cross-sectional study, 18 post-surgical and 14 control women were assessed for hormonal and metabolic responses to an alcohol dose. Alcohol decreased GLP-1 by 34% in both groups and reduced ghrelin more in controls (27%) than in the surgery group (13%). Alcohol modestly lowered glucose and transiently increased insulin secretion in both groups. However, 28% of post-surgical women reached hypoglycemic levels, compared to none in the control group. In the longitudinal arm, seven women underwent identical alcohol/placebo challenges before and ~5 months after surgery. We observed that post-surgery, blood alcohol concentrations (BAC) peaked faster and higher, with ~28% lower alcohol clearance, likely reflecting the loss of fat-free mass. However, the acute decrease of GLP-1 and marked increase of fibroblast growth factor 21 (FGF21) following alcohol intake did not significantly differ before and after surgery. Similarly, alcohol-induced glucose reductions were not more pronounced postoperatively. Together, these findings confirm that acute alcohol consumption reduces endogenous GLP-1 and increases hypoglycemia risk after metabolic surgery. They also suggest that, despite substantial weight loss and improvements in insulin sensitivity post-surgery, acute endocrine responses to alcohol in a fasted state remain largely comparable. These insights support the relevance of gut–brain and liver–brain peptide systems in understanding alcohol's effects and AUD risk in surgical populations.</dc:description>
          <dc:date>2025-08</dc:date>
          <dc:type>Text</dc:type>
          <dc:identifier>https://hdl.handle.net/2142/129981</dc:identifier>
          <dc:rights>Copyright 2025 Mariel Molina Castro</dc:rights>
          <degree>
            <department>Food Science &amp; Human Nutrition</department>
            <discipline>Food Science &amp; Human Nutrition</discipline>
            <grantor>University of Illinois Urbana-Champaign</grantor>
            <name>M.S.</name>
            <level>Thesis</level>
          </degree>
        </thesis>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
